brigatinib

Name: Pharmaffiliates
Address: Plot Number 225 ,Industrial Area, Phase II, Panchkula, 134109, IN
Telephone: +91-172-5066494
Price range: $650-$950

Brigatinib acts as both an anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) inhibitor. It is a small molecule targeted cancer therapy being developed by ARIAD Pharmaceuticals, Inc.. Reference standards of Brigatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Brigatinib - API Standards 
    [catalogue_number] => PA 29 44000
    [category_ids] => ,78,72,80,79,
    [chemical_name] => 
    [weight] => 584.09
    [form] => C29H39ClN7O2P
    [cas] => 1197953-54-0
    [pslug] => 1197953-54-0-brigatinib-api-pa2944000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)